We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$388M
AUM Growth
+$41.7M
Cap. Flow
+$16.2M
Cap. Flow %
4.17%
Top 10 Hldgs %
24.25%
Holding
310
New
44
Increased
124
Reduced
95
Closed
9

Top Sells

Rank Stock Value
1
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$2.47M
2
SYNA icon
Synaptics
SYNA
+$1.51M
3
CAT icon
Caterpillar
CAT
+$1.47M
4
WFC icon
Wells Fargo
WFC
+$1.2M
5
CVS icon
CVS Health
CVS
+$858K

Sector Composition

Rank Sector Weight
1 Healthcare 16.34%
2 Technology 14.94%
3 Financials 10.75%
4 Industrials 9.18%
5 Energy 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.72T
$15.2M 3.93%
207,496
-1,948
-0.9% -$125K
JNJ icon
2
Johnson & Johnson
JNJ
$624B
$13.5M 3.47%
92,238
+2,648
+3% +$359K
MSFT icon
3
Microsoft
MSFT
$2.83T
$12.4M 3.2%
78,674
+9,292
+13% +$1.37M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.06T
$9.02M 2.33%
39,840
+1,058
+3% +$230K
XOM icon
5
ExxonMobil
XOM
$650B
$8.27M 2.13%
118,506
+454
+0.4% +$31.4K
PEP icon
6
PepsiCo
PEP
$184B
$7.62M 1.96%
55,755
-181
-0.3% -$24.6K
JPM icon
7
JPMorgan Chase
JPM
$930B
$7.42M 1.91%
53,238
+5,934
+13% +$761K
T icon
8
AT&T
T
$160B
$6.99M 1.8%
236,645
+6,374
+3% +$184K
ABBV icon
9
AbbVie
ABBV
$454B
$6.96M 1.79%
78,594
+4,919
+7% +$408K
VZ icon
10
Verizon
VZ
$183B
$6.66M 1.72%
108,436
+5,454
+5% +$329K
HD icon
11
Home Depot
HD
$324B
$5.73M 1.48%
26,242
+898
+4% +$203K
CVS icon
12
CVS Health
CVS
$136B
$5.51M 1.42%
74,136
-12,219
-14% -$858K
PG icon
13
Procter & Gamble
PG
$342B
$5.11M 1.32%
40,874
+1,849
+5% +$226K
ABT icon
14
Abbott
ABT
$175B
$4.76M 1.23%
54,803
+1,597
+3% +$134K
CVX icon
15
Chevron
CVX
$387B
$4.42M 1.14%
36,704
+72
+0.2% +$8.48K
GOOG icon
16
Alphabet (Google) Class C
GOOG
$3.88T
$4.29M 1.11%
64,140
+380
+0.6% +$24.5K
EPD icon
17
Enterprise Products Partners
EPD
$83.9B
$4.24M 1.09%
150,507
+28,546
+23% +$774K
BDX icon
18
Becton Dickinson
BDX
$42.1B
$4.23M 1.09%
15,933
+324
+2% +$80.8K
EMR icon
19
Emerson Electric
EMR
$81.2B
$3.78M 0.98%
49,576
+2,463
+5% +$177K
BAC icon
20
Bank of America
BAC
$430B
$3.75M 0.97%
106,587
+4,158
+4% +$134K
MCD icon
21
McDonald's
MCD
$187B
$3.72M 0.96%
18,808
+2,381
+14% +$472K
HON icon
22
Honeywell
HON
$78B
$3.63M 0.94%
21,748
+578
+3% +$94.5K
DIS icon
23
Walt Disney
DIS
$161B
$3.58M 0.92%
24,784
+1,352
+6% +$189K
WTRG icon
24
Essential Utilities
WTRG
$11.2B
$3.48M 0.9%
74,226
+25,740
+53% +$1.16M
MRK icon
25
Merck
MRK
$322B
$3.38M 0.87%
39,003
+3,695
+10% +$303K

Similar funds

Boenning & Scattergood's Q4 2019 Portfolio in Review

As of Q4 2019, Boenning & Scattergood held 310 positions worth $388M, up 12% from $346M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boenning & Scattergood deployed $16.2M of net new capital in Q4 2019, opening 44 new positions and adding to 124 existing holdings. Its largest new stake was Global X MLP & Energy Infrastructure ETF: 26,475 shares worth $975K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SPDR Gold MiniShares Trust, an estimated $2.47M trimmed.

  • Boenning & Scattergood's largest Q4 2019 buy was Global X MLP & Energy Infrastructure ETF: 26,475 shares worth $975K.
  • Boenning & Scattergood added most to Microsoft in Q4 2019, an estimated $1.37M increase.
  • Boenning & Scattergood's biggest Q4 2019 reduction was SPDR Gold MiniShares Trust, cutting an estimated $2.47M.
  • Boenning & Scattergood fully exited Vanguard Total International Stock ETF in Q4 2019, selling an estimated $730K.
  • Boenning & Scattergood's ten largest holdings make up 24% of its $388M portfolio in Q4 2019.
  • Boenning & Scattergood opened 44 new positions and closed 9 in Q4 2019.
  • Boenning & Scattergood's portfolio value rose 12% quarter-over-quarter to $388M.

Based on Boenning & Scattergood's 13F filing for Q4 2019, filed 15 Jan 2020.